Validation of a liquid biopsy based molecular diagnostic toolkit for pediatric sarcomas
Dauer: 48 Monate, Fördersumme: € 899.160
Deciphering genomic aberrations in rare skin cancers to find mechanism-based treatment strategies
Dauer: 82 Monate, Fördersumme: € 972.100